Companies To Watch

Companies To Watch: Freya Biosciences

Freya Biosciences is enlivening the long-time lonely space of reproductive health, starting with a new focus on the vaginal microbiome.

Companies To Watch: Spruce Biosciences

Spruce Biosciences is currently in mid-to-late stage clinical development of new agents to treat rare endocrine disorders.

Companies To Watch: Nido Biosciences

See why Nido Biosciences is developing small molecule drugs for rare neurodegenerative diseases.

Companies To Watch: Ventoux Biosciences

Why Ventoux Biosciences is pursuing drug treatments for all sufferers of Dupuytren’s and other fibroproliferative diseases.

Companies To Watch: Kinaset Therapeutics

Kinaset Therapeutics is moving fast in the respiratory space to advance a potential first-time therapy.

Companies To Watch: Orca Bio

Orca Bio is creating a new cell therapy aimed at bringing rebirth to stem-cell transplantation.

Companies To Watch: Sonoma Biotherapeutics

Sonoma Biotherapeutics is bioengineering T cells to create potential cures for autoimmune and inflammatory conditions.

Companies To Watch: KaliVir Immunotherapeutics

KaliVir Immunotherapeutics is engineering oncolytic viruses with novel transgenes, and joining them to other immunotherapies, to defeat cancer and cancer relapse.

Companies To Watch: Hummingbird Bioscience

Hummingbird Bioscience is joining the forces of computational and systems biology to fight cancer and autoimmune disease.

Companies To Watch: Corner Therapeutics

Corner Therapeutics is focused on discovering new small molecules that could mimic the body’s natural immune response to generate the robust T-cell response.

Companies To Watch: Ocelot Bio

Ocelot Bio is focusing a single drug on multiple complications of end-stage liver disease.

Companies To Watch: iTolerance

iTolerance is dedicated to curing diabetes and other conditions by inducing local immune tolerance in implantation.

Companies To Watch: CytoAgents

CytoAgents is combatting the broad areas of disease stemming from a common cause: cytokine release syndrome.

Companies To Watch: Viking Therapeutics

Viking Therapeutics is a broad-target contender for treating NASH in a pipeline of new drugs for metabolic and endocrine disorders.